| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021
Human tumors may contain high concentrations of ascorbic acid, but little is known about how they acquire the vitamin. Certain specialized cells can transport ascorbic acid directly through a sodium ascorbate cotransporter, but in most cells, vitamin C enters through the facilitative glucose transporters (GLUTs) in the form of dehydroascorbic acid, which is then reduced intracellularly and retained as ascorbic acid. Mice with established hematopoietic and epithelial cell xenografts were studied for the accumulation of injected ascorbic acid and dehydroascorbic acid. Most hematopoietic and epithelial tumor cell lines can only transport vitamin C in the oxidized form (dehydroascorbic acid) in vitro; however, when grown as xenografts in mice, they rapidly accumulated vitamin C after administration of radiolabeled ascorbic acid. The involvement of the GLUTs in vitamin C uptake by the xenografted tumors was demonstrated by competitive inhibition with D-glucose but not L-glucose. Because the malignant cells were not capable of directly transporting ascorbic acid, we reasoned that the ascorbic acid was oxidized to dehydroascorbic acid in the tumor microenvironment. Tumor accumulation of vitamin C in animals injected with ascorbic acid was inhibited by coadministration of superoxide dismutase, implying a role for superoxide anion in the oxidation of ascorbic acid. Whereas the epithelial cancer cell lines could not generate superoxide anion in culture, the minced xenograft tumors did. Our studies show the transport of dehydroascorbic acid by GLUTs is a means by which tumors acquire vitamin C and indicate the oxidation of ascorbic acid by superoxide anion produced by cells in the tumor stroma as a mechanism for generating the transportable form of the vitamin.
This article has been cited by other articles:
|
|
 |
|
  M. G. Espey, Q. Chen, and M. Levine Comment re: Vitamin C Antagonizes the Cytotoxic Effects of Chemotherapy Cancer Res., November 15, 2009; 69(22): 8830 - 8830. [Full Text] [PDF]
|
|
|
|
 |
|
 N. PHILIPS, L. DULAJ, and T. UPADHYA Cancer Cell Growth and Extracellular Matrix Remodeling Mechanism of Ascorbate; Beneficial Modulation by P. leucotomos Anticancer Res, August 1, 2009; 29(8): 3233 - 3238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. OHNO, Y. OHNO, N. SUZUKI, G.-I. SOMA, and M. INOUE High-dose Vitamin C (Ascorbic Acid) Therapy in the Treatment of Patients with Advanced Cancer Anticancer Res, March 1, 2009; 29(3): 809 - 815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Beck, J. Verrax, N. Dejeans, H. Taper, and P. B. Calderon Menadione Reduction by Pharmacological Doses of Ascorbate Induces an Oxidative Stress That Kills Breast Cancer Cells International Journal of Toxicology, January 1, 2009; 28(1): 33 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Heaney, J. R. Gardner, N. Karasavvas, D. W. Golde, D. A. Scheinberg, E. A. Smith, and O. A. O'Connor Vitamin C Antagonizes the Cytotoxic Effects of Antineoplastic Drugs Cancer Res., October 1, 2008; 68(19): 8031 - 8038. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. D. Lawenda, K. M. Kelly, E. J. Ladas, S. M. Sagar, A. Vickers, and J. B. Blumberg Should Supplemental Antioxidant Administration Be Avoided During Chemotherapy and Radiation Therapy? J Natl Cancer Inst, June 4, 2008; 100(11): 773 - 783. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. Parsons, N. Maeda, M. Yamauchi, A. J. Banes, and B. H. Koller Ascorbic acid-independent synthesis of collagen in mice Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1131 - E1139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Gonzalez and J. R. Miranda-Massari Advances in Vitamin C Research Integr Cancer Ther, March 1, 2006; 5(1): 7 - 8. [PDF]
|
|
|
|
 |
|
 N. Karasavvas, J. M. Carcamo, G. Stratis, and D. W. Golde Vitamin C protects HL60 and U266 cells from arsenic toxicity Blood, May 15, 2005; 105(10): 4004 - 4012. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Gonzalez, J. R. Miranda-Massari, E. M. Mora, A. Guzman, N. H. Riordan, H. D. Riordan, J. J. Casciari, J. A. Jackson, and A. Roman-Franco Orthomolecular Oncology Review: Ascorbic Acid and Cancer 25 Years Later Integr Cancer Ther, March 1, 2005; 4(1): 32 - 44. [Abstract] [PDF]
|
|
|
|
|
|
T. Mikuni, G. He, S. Petryakov, M. M. Fallouh, Y. Deng, R. Ishihara, P. Kuppusamy, M. Tatsuta, and J. L. Zweier In vivo Detection of Gastric Cancer in Rats by Electron Paramagnetic Resonance Imaging Cancer Res., September 15, 2004; 64(18): 6495 - 6502. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Lutsenko, J. M. Carcamo, and D. W. Golde A Human Sodium-Dependent Vitamin C Transporter 2 Isoform Acts as a Dominant-Negative Inhibitor of Ascorbic Acid Transport Mol. Cell. Biol., April 15, 2004; 24(8): 3150 - 3156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Ladas, J. S. Jacobson, D. D. Kennedy, K. Teel, A. Fleischauer, and K. M. Kelly Antioxidants and Cancer Therapy: A Systematic Review J. Clin. Oncol., February 1, 2004; 22(3): 517 - 528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Golde Vitamin C in Cancer Integr Cancer Ther, June 1, 2003; 2(2): 158 - 159. [PDF]
|
|
|
|
 |
|
 J. A. Drisko, J. Chapman, and V. J. Hunter The Use of Antioxidants with First-Line Chemotherapy in Two Cases of Ovarian Cancer J. Am. Coll. Nutr., April 1, 2003; 22(2): 118 - 123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Nualart, C. I. Rivas, V. P. Montecinos, A. S. Godoy, V. H. Guaiquil, D. W. Golde, and J. C. Vera Recycling of Vitamin C by a Bystander Effect J. Biol. Chem., March 14, 2003; 278(12): 10128 - 10133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K R Martin and J C Barrett Reactive oxygen species as double-edged swords in cellular processes: low-dose cell signaling versus high-dose toxicity Human and Experimental Toxicology, February 1, 2002; 21(2): 71 - 75. [Abstract] [PDF]
|
|
|
|
 |
|
 Z-W Zhang, M Abdullahi, and M J G Farthing Effect of physiological concentrations of vitamin C on gastric cancer cells and Helicobacter pylori Gut, February 1, 2002; 50(2): 165 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Cinar, K. S. Koeneman, M. Edlund, G. S. Prins, H. E. Zhau, and L. W. K. Chung Androgen Receptor Mediates the Reduced Tumor Growth, Enhanced Androgen Responsiveness, and Selected Target Gene Transactivation in a Human Prostate Cancer Cell Line Cancer Res., October 1, 2001; 61(19): 7310 - 7317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. R. Martin, C. Trempus, M. Saulnier, F. W. Kari, J.C. Barrett, and J. E. French Dietary N-acetyl-L-cysteine modulates benzo[a]pyrene-induced skin tumors in cancer-prone p53 haploinsufficient Tg.AC (v-Ha-ras) mice Carcinogenesis, September 1, 2001; 22(9): 1373 - 1378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. H. Guaiquil, J. C. Vera, and D. W. Golde Mechanism of Vitamin C Inhibition of Cell Death Induced by Oxidative Stress in Glutathione-depleted HL-60 Cells J. Biol. Chem., October 26, 2001; 276(44): 40955 - 40961. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
